Research

AI can Speed Design of Health Software

Artificial intelligence (AI) helped clinicians to accelerate the design of diabetes prevention software, a new study finds.

Publishing online March 6 in the Journal of Medical Internet Research, the study examined the capabilities of a form of artificial intelligence called generative AI or GenAI, which predicts likely options for the next word in any sentence based on how billions of people used words in context on the internet.

NHS Scotland's Right Decision Service Built on Tactuum Technology

Clinicians in Scotland have easy access to clinical guidelines and validated decision support tools using the Right Decision Service (RDS), built on technology developed by Tactuum.

The RDS is a once-for-Scotland national project funded by the Scottish Government and run by Healthcare Improvement Scotland.

AI Reveals Prostate Cancer is Not Just One Disease

Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future.

A Cancer Research UK-funded study reveals that prostate cancer, which affects one in eight men in their lifetime, includes two different subtypes termed evotypes.

International Team Led by BSC Develops AI Technology to Improve Treatment of Rare Diseases

An international team of scientists led by ICREA researcher and Director of the Life Sciences Department at the Barcelona Supercomputing Centre - Centro Nacional de Supercomputación (BSC-CNS), Alfonso Valencia, has developed a technology based on artificial intelligence (AI) for the study of minority diseases and has successfully applied it to identify the possible causes of the appearance of what are known as myasthenic-congenital syndromes, a group of rare inherited disorders that limit the ability to move and cause varying degrees of muscle weakness in patients.

For Type II Diabetes Prevention, Tap into AI

Better prevention of Type II diabetes could save both lives and money. The U.S. spends over $730 billion a year - nearly a third of all health care spending - on treating preventable diseases like diabetes.

For the 98 million adults who are prediabetic and at risk of developing Type II diabetes, preventive treatments such as the drug metformin can help stave off the disease.

AI Matches or Outperforms Human Specialists in Retina and Glaucoma Management

A large language model (LLM) artificial intelligence (AI) system can match, or in some cases outperform, human ophthalmologists in the diagnosis and treatment of patients with glaucoma and retina disease, according to research from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

The provocative study, published February 22, in JAMA Ophthalmology, suggests that advanced AI tools, which are trained on vast amounts of data, text, and images,

Improving Efficiency, Reliability of AI Medical Summarization Tools

Medical summarization, a process that uses artificial intelligence (AI) to condense complex patient information, is currently used in health care settings for tasks such as creating electronic health records and simplifying medical text for insurance claims processing. While the practice is intended to create efficiencies, it can be labor-intensive, according to Penn State researchers, who created a new method to streamline the way AI creates these summaries, efficiently producing more reliable results.

More eHealth News ...